AIMC Topic: Drug-Related Side Effects and Adverse Reactions

Clear Filters Showing 171 to 180 of 322 articles

Network-Based Assessment of Adverse Drug Reaction Risk in Polypharmacy Using High-Throughput Screening Data.

International journal of molecular sciences
The risk of adverse drug reactions increases in a polypharmacology setting. High-throughput drug screening with transcriptomics applied to human cells has shown that drugs have effects on several molecular pathways, and these affected pathways may be...

A classification framework for exploiting sparse multi-variate temporal features with application to adverse drug event detection in medical records.

BMC medical informatics and decision making
BACKGROUND: Adverse drug events (ADEs) as well as other preventable adverse events in the hospital setting incur a yearly monetary cost of approximately $3.5 billion, in the United States alone. Therefore, it is of paramount importance to reduce the ...

eToxPred: a machine learning-based approach to estimate the toxicity of drug candidates.

BMC pharmacology & toxicology
BACKGROUND: The efficiency of drug development defined as a number of successfully launched new pharmaceuticals normalized by financial investments has significantly declined. Nonetheless, recent advances in high-throughput experimental techniques an...

Predicting adverse drug reactions through interpretable deep learning framework.

BMC bioinformatics
BACKGROUND: Adverse drug reactions (ADRs) are unintended and harmful reactions caused by normal uses of drugs. Predicting and preventing ADRs in the early stage of the drug development pipeline can help to enhance drug safety and reduce financial cos...

Similarity-based machine learning support vector machine predictor of drug-drug interactions with improved accuracies.

Journal of clinical pharmacy and therapeutics
WHAT IS KNOWN AND OBJECTIVE: Drug-drug interactions (DDI) are frequent causes of adverse clinical drug reactions. Efforts have been directed at the early stage to achieve accurate identification of DDI for drug safety assessments, including the devel...

Innovation in Pharmacovigilance: Use of Artificial Intelligence in Adverse Event Case Processing.

Clinical pharmacology and therapeutics
Automation of pharmaceutical safety case processing represents a significant opportunity to affect the strongest cost driver for a company's overall pharmacovigilance budget. A pilot was undertaken to test the feasibility of using artificial intellig...

An automated pipeline for analyzing medication event reports in clinical settings.

BMC medical informatics and decision making
BACKGROUND: Medication events in clinical settings are significant threats to patient safety. Analyzing and learning from the medication event reports is an important way to prevent the recurrence of these events. Currently, the analysis of medicatio...

Adverse Drug Reaction Predictions Using Stacking Deep Heterogeneous Information Network Embedding Approach.

Molecules (Basel, Switzerland)
Inferring potential adverse drug reactions is an important and challenging task for the drug discovery and healthcare industry. Many previous studies in computational pharmacology have proposed utilizing multi-source drug information to predict drug ...

Tox_(R)CNN: Deep learning-based nuclei profiling tool for drug toxicity screening.

PLoS computational biology
Toxicity is an important factor in failed drug development, and its efficient identification and prediction is a major challenge in drug discovery. We have explored the potential of microscopy images of fluorescently labeled nuclei for the prediction...

Identification of Drug-Side Effect Association via Semisupervised Model and Multiple Kernel Learning.

IEEE journal of biomedical and health informatics
Drug-side effect association contains the information on marketed medicines and their recorded adverse drug reactions. Traditional experimental method is time consuming and expensive. All associations of drugs and side-effects are seen as a bipartite...